LEP and breast carcinoma: To the best of our knowledge, few studies evaluated leptin expression in breast cancer tissues (Table 2) [31–40] of which the outcomes failed to confirm the results of leptin serological studies and the correlation of leptin immunoexpression with clinicopathological findings of breast carcinoma patients.